Founded by a team of accomplished investment professionals with extensive and complementary industry backgrounds, Clarus Ventures is a life sciences venture capital firm with a team that has a long history of success in creating value.  More Info

7/19/2010

Independent peer-reviewed study demonstrates that T-SPOT®.TB assay outperforms tuberculin skin test in predicting tuberculosis disease

6/29/2010

NanoString Technologies Announces Key Executive Management Appointments

6/25/2010

The T-SPOT®.TB Test Now Included in New CDC Guidelines TB Blood Tests Preferred for Targeted Groups

» More News

Boston
101 Main Street Suite 1210
Cambridge, MA 02142
T: 617.949.2200
F: 617.949.2201

San Francisco
801 Gateway Boulevard, Suite 410
South San Francisco, CA 94080
T: 650.238.5000
F: 650.238.5001

» Contact Us